Human Herpesviruses: Varicella and Herpes Zoster
Reference323 articles.
1. Abreu ESHB, Corrêa HP, Ribeiro IA, Nascimento VAM, Greco CM, Pinto ICT, Teixeira DC, Diniz LMO, Ribeiro JGL. Impact of six years of routine varicella vaccination on the disease-related hospitalizations at Minas Gerais, Brazil. Vaccine. 2022;40:390–5.
2. ACIP. Recommended child and adolescent immunization schedule for ages 18 years or younger (2022).
3. Amlie-Lefond C, Jubelt B. Neurologic manifestations of varicella zoster virus infections. Curr Neurol Neurosci Rep. 2009;9:430–4.
4. Anderson TC, Masters NB, Guo A, Shepersky L, Leidner AJ, Lee GM, Kotton CN, Dooling KL. Use of recombinant zoster vaccine in immunocompromised adults aged ≥19 years: recommendations of the advisory committee on immunization practices – United States, 2022. MMWR Morb Mortal Wkly Rep. 2022;71:80–4.
5. Armenian SH, Han JY, Dunaway TM, Church JA. Safety and immunogenicity of live varicella virus vaccine in children with human immunodeficiency virus type 1. Pediatr Infect Dis J. 2006;25:368–70.